Vascular Surgery Division, University of Campus Bio-Medico, Rome, Italy.
Vascular and Endovascular Surgery Division, Department of Surgery "Paride Stefanini", Policlinico Umberto I, "Sapienza" University of Rome, Italy.
Ann Vasc Surg. 2021 Jul;74:183-193. doi: 10.1016/j.avsg.2020.12.048. Epub 2021 Feb 4.
to evaluate the impact of bi- and 3-dimensional preoperative aortic morphological features and their immediate postoperative variations on the outcome of abdominal aortic aneurysms (AAA) treated by endovascular exclusion with standard devices (EVAR).
Double centre retrospective analysis of prospectively collected registry data of EVAR patients. For all patients, preoperative and 30-day computed tomographic angiography images (CTA) were reviewed. Preoperative maximum AAA diameter >59 mm and volume >159 cm, and any 30-day postoperative increasing at CTA, were considered as potentially influencing the outcome. The outcome measures were: primary technical success; 30-day, 1-year, and mean follow-up reintervention, all-cause and AAA-related mortality rates, and also endoleak-related reinterventions.
Three hundred and thrity-three patients were enrolled. Mean preoperative and 30-day AAA diameter and volume were 50.4 mm ± 11.8 vs. 49.1 mm ± 12.1, and 112.9 cm3 ± 79.5 vs. 112.1 cm3 ± 80.5, respectively. Primary technical success was achieved in all cases. At 34.9 months follow-up, cumulative reintervention rate was 12.0%, mortality rates 7.2%, without AAA-related deaths. Endoleak-related reintervention rate was 7.5%. At uni- and multi-variate analysis, preoperative AAA diameter >59 mm, and AAA volume >159 cm were significantly associated to reintervention (P = 0.012; P = 0.002), and reintervention and death (P = 0.002; P = 0.001) during follow-up. Additionally, any increase in postoperative AAA diameter or volume was significantly associated with reintervention (P = 0.001, P = 0.001) and reintervention and death (P = 0.006, P = 0.001). Endoleak-related reintervention were also significantly associated with all of the analysed morphological parameters (P = 0.019, P = 0.005, P = 0.005, and P = 0.002, respectively).
Patients with larger baseline AAA size and volume as well as unfavourable early remodelling of the sac are associated to worse long-term EVAR outcome.
评估术前主动脉形态的二维和三维特征及其术后即刻变化对使用标准器械行腹主动脉瘤腔内修复术(EVAR)治疗的腹主动脉瘤(AAA)结果的影响。
对前瞻性收集的 EVAR 患者注册数据进行双中心回顾性分析。对所有患者进行术前和 30 天 CT 血管造影(CTA)检查。术前 AAA 最大直径>59mm 且体积>159cm3,以及任何 30 天 CTA 术后增加,被认为可能影响结果。主要研究终点为:主要技术成功;30 天、1 年和平均随访时再干预、全因和 AAA 相关死亡率,以及与内漏相关的再干预。
共纳入 333 例患者。平均术前和 30 天 AAA 直径和体积分别为 50.4mm±11.8vs.49.1mm±12.1,112.9cm3±79.5vs.112.1cm3±80.5。所有病例均获得主要技术成功。34.9 个月随访时,累积再干预率为 12.0%,死亡率为 7.2%,无 AAA 相关死亡。与内漏相关的再干预率为 7.5%。单因素和多因素分析显示,术前 AAA 直径>59mm 和 AAA 体积>159cm3 与再干预(P=0.012;P=0.002)以及随访期间的再干预和死亡(P=0.002;P=0.001)显著相关。此外,术后 AAA 直径或体积任何增加均与再干预(P=0.001,P=0.001)以及再干预和死亡(P=0.006,P=0.001)显著相关。与内漏相关的再干预也与所有分析的形态学参数显著相关(P=0.019,P=0.005,P=0.005,P=0.002)。
基线 AAA 较大且体积较大,以及早期瘤腔重塑不良的患者与 EVAR 治疗的长期预后较差相关。